Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Totalis (AT)”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Not applicableAvailableNCT05522556
What this trial is testing

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Who this might be right for
Alopecia Areata
Pfizer
Testing effectiveness (Phase 2)Study completedNCT02197455
What this trial is testing

Tofacitnib for the Treatment of Alopecia Areata and Variants

Who this might be right for
Alopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU)
Yale University 30
Large-scale testing (Phase 3)Study completedNCT06278402
What this trial is testing

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Jinnah Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03315689
What this trial is testing

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia Universalis (AU)Alopecia Totalis (AT)
Aclaris Therapeutics, Inc. 11
Testing effectiveness (Phase 2)Ended earlyNCT03759340
What this trial is testing

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia AreataAlopecia UniversalisAlopecia Totalis
Aclaris Therapeutics, Inc. 56
Post-approval studies (Phase 4)Looking for participantsNCT07381556
What this trial is testing

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

Who this might be right for
Alopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more
Erasmus Medical Center 50